📣 AstraZeneca Bets on AI for Cancer Treatments

posted  4 Dec 2023
Photo - AstraZeneca Bets on AI for Cancer Treatments
Pharmaceutical giant AstraZeneca signed a $247 million deal with biotech firm Absci, specializing in AI-driven drug development. This partnership aims to innovate cancer treatment methods.

"We're proud to work closely with AstraZeneca to leverage our AI to bring novel treatments to oncology patients," Absci CEO Sean McClain said.

The ultimate goal of this collaboration is to develop a generative AI model capable of proposing new therapies or enhancing existing ones. However, the specific cancer types targeted in this initiative remain unspecified.